What is a stock summary page? Click here for an overview.
Business Description
Precipio Inc
NAICS : 334516
SIC : 3826
ISIN : US74019L1070
Description
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.82 | |||||
| Equity-to-Asset | 0.71 | |||||
| Debt-to-Equity | 0.11 | |||||
| Debt-to-EBITDA | -0.88 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -6.88 | |||||
| Beneish M-Score | -3.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 16.6 | |||||
| 3-Year EBITDA Growth Rate | 32.1 | |||||
| 3-Year EPS without NRI Growth Rate | 28 | |||||
| 3-Year FCF Growth Rate | 32.4 | |||||
| 3-Year Book Growth Rate | -14.2 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.1 | |||||
| 9-Day RSI | 33.44 | |||||
| 14-Day RSI | 39.56 | |||||
| 3-1 Month Momentum % | 37.53 | |||||
| 6-1 Month Momentum % | 15.42 | |||||
| 12-1 Month Momentum % | 22.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.73 | |||||
| Quick Ratio | 0.6 | |||||
| Cash Ratio | 0.24 | |||||
| Days Inventory | 19.46 | |||||
| Days Sales Outstanding | 24.39 | |||||
| Days Payable | 38.96 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.3 | |||||
| Shareholder Yield % | 0.36 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.78 | |||||
| Operating Margin % | -27.19 | |||||
| Net Margin % | -17.23 | |||||
| FCF Margin % | -0.35 | |||||
| ROE % | -23.36 | |||||
| ROA % | -17.04 | |||||
| ROIC % | -29.96 | |||||
| 3-Year ROIIC % | -67.73 | |||||
| ROC (Joel Greenblatt) % | -193.91 | |||||
| ROCE % | -21.99 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 7.63 | |||||
| PS Ratio | 0.52 | |||||
| PB Ratio | 0.78 | |||||
| EV-to-EBIT | -3.43 | |||||
| EV-to-EBITDA | -6.98 | |||||
| EV-to-Revenue | 0.58 | |||||
| EV-to-Forward-Revenue | 0.32 | |||||
| EV-to-FCF | -165.69 | |||||
| Price-to-GF-Value | 0.34 | |||||
| Earnings Yield (Greenblatt) % | -29.15 | |||||
| FCF Yield % | -0.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PRPO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Precipio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 17.411 | ||
| EPS (TTM) ($) | -1.83 | ||
| Beta | 1.11 | ||
| 3-Year Sharpe Ratio | -0.48 | ||
| 3-Year Sortino Ratio | -0.75 | ||
| Volatility % | 45.47 | ||
| 14-Day RSI | 39.56 | ||
| 14-Day ATR ($) | 0.569406 | ||
| 20-Day SMA ($) | 7.01737 | ||
| 12-1 Month Momentum % | 22.05 | ||
| 52-Week Range ($) | 4.31 - 10.7425 | ||
| Shares Outstanding (Mil) | 1.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Precipio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Precipio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Precipio Inc Frequently Asked Questions
What is Precipio Inc(PRPO)'s stock price today?
The current price of PRPO is $6.26. The 52 week high of PRPO is $10.74 and 52 week low is $4.31.
When is next earnings date of Precipio Inc(PRPO)?
The next earnings date of Precipio Inc(PRPO) is 2025-03-31.
Does Precipio Inc(PRPO) pay dividends? If so, how much?
Precipio Inc(PRPO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers